Capricor Therapeutics Announces Positive Topline Results from Pivotal Phase 3 HOPE-3 Study of Deramiocel in Duchenne Muscular Dystrophy
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 02/14/20 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 02/14/20 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 02/14/20 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 02/14/20 | Statement of changes in beneficial ownership of securities |
|
2 | ||
| 12/27/19 | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
10 | ||
| 12/19/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/19/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/19/19 | Statement of changes in beneficial ownership of securities |
|
1 | ||
| 12/19/19 | Current report filing |
|
5 | ||
| 12/19/19 | Prospectus filed pursuant to Rule 424(b)(4) |
|
58 |